Similar Posts
Viagra: Can BBC show help men talk about erectile dysfunction?
Stars and doctors hope Russell T Davies’s BBC drama Men Up can help end impotence stigma.
Is your Christmas tree causing allergies? What experts say about
‘Tis the season for sneezing and coughing — but in some cases, it may not be seasonal germs but the Christmas tree in your living room that’s making you feel those symptoms. Sometimes referred to as “Christmas Tree Syndrome,” experts say it can cause your indoor allergies to flare up around the holiday. It’s not an…
At-home health test maker Thorne explores sale | Reuters News Agency
Business & FinanceDealsHealth 21 July 2023, 6:41 pm 1 minute Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale. Market Impact Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million….
7 Things Stroke Doctors Say You Should Never, Ever Do
In the United States, strokes are a top cause of death and a major cause of disability, according to the American Stroke Association. This is a scary reality, especially since many of the stroke risk factors are pretty silent (like high cholesterol and high blood pressure) ― until they’re not. But just because some of…
Cigna explores shedding Medicare Advantage business | Reuters News Agency
DealsGovernmentHealth 06 November 2023, 6:28 pm 1 minute Reuters was first to report that U.S. health insurer Cigna Group (CI.N) is exploring the sale of its Medicare Advantage business, which manages government health insurance for people aged 65 and older, a move that would mark a reversal of its expansion in the sector. Market Impact…
Weight loss drugs, Alzheimer’s treatments and gene editing: Enormous firsts defined 2023 in pharma
Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutical industry in 2024 and beyond. The weight loss drug market transformed into the pharmaceutical industry’s newest gold rush this year, as demand for costly but highly effective treatments from Novo Nordisk…
